IL-35

IL-35 is an anti-inflammatory cytokine in Immunobiology, mainly made by regulatory T cells and some B cells. It suppresses effector immune cells and helps tumors escape immune attack.

What is IL-35?

IL-35 is an immunosuppressive cytokine in Immunobiology, usually discussed as part of how the immune system gets turned down inside tumors. It belongs to the interleukin-12 family, but unlike many cytokines that push immune cells into attack mode, IL-35 pushes responses toward tolerance and restraint.

The main sources you should remember are regulatory T cells, or Tregs, and some B cells. That matters because these are not ordinary “attack” cells. They are part of the immune system’s brake system, and IL-35 is one of the signals they use to slow down other immune cells.

IL-35 works by reducing the proliferation and activity of effector T cells, the cells that would normally expand and kill infected or abnormal targets. It also suppresses natural killer cells, which are part of the early anti-tumor response. When IL-35 is present at higher levels, the immune response becomes less aggressive and less able to clear cancer cells.

A useful way to picture IL-35 is as a signal that strengthens immune restraint in the tumor microenvironment. Tumors can take advantage of that by encouraging more suppressive signaling around them. Instead of a clean immune attack, the area around the tumor becomes a place where T cells are less active, NK cells are less effective, and Tregs can expand.

That feedback loop is why IL-35 comes up in tumor immune evasion. It does not create cancer by itself, but it helps cancer hide in plain sight by changing the local immune environment. If you see IL-35 in a case, the big idea is not just “a cytokine was present,” but “the immune system was being pushed toward tolerance rather than attack.”

Why IL-35 matters in IMMUNOBIOLOGY

IL-35 matters because it connects immune signaling to one of the biggest themes in Immunobiology, tumor immune evasion. When you study cancer and immunity, you are not only asking whether immune cells exist near a tumor. You are asking whether those cells are actually functioning, or whether local signals are shutting them down.

IL-35 is a clean example of how tumors can benefit from the body’s own regulatory pathways. Tregs and some B cells use it to suppress effector T cells and NK cells, which lowers anti-tumor activity. That means a tumor can survive not just by hiding its antigens, but by living in an environment where immune responses are actively dampened.

This term also helps you connect cytokine biology to treatment ideas. If a tumor shows high IL-35, that can point toward a more suppressive tumor microenvironment and a worse prognosis. It also raises the question of whether blocking that signal could make immune-based therapies work better.

In class, IL-35 gives you a concrete example of how immune regulation can be protective in one setting and harmful in another. Tolerance is useful when you are preventing autoimmunity, but inside a tumor it can give cancer cells breathing room.

How IL-35 connects across the course

Regulatory T cells (Tregs)

Tregs are one of the main sources of IL-35, so they sit upstream of its suppressive effects. When Tregs expand in a tumor, they can increase local immune restraint and make it harder for effector T cells to stay active. That is why IL-35 is often discussed as part of the same suppressive network as Tregs.

Tumor Microenvironment

IL-35 acts inside the tumor microenvironment, not as a random bloodstream signal. The local environment around a tumor can become packed with suppressive cytokines, inhibitory cells, and weak effector responses. IL-35 helps tip that environment away from immune attack and toward tolerance.

natural killer cells

Natural killer cells are part of the early anti-tumor response, so IL-35’s suppression of NK cell activity matters a lot. If NK cells cannot proliferate or stay active, the body loses one of its faster ways to detect abnormal cells. This makes IL-35 a useful example of immune evasion at the innate-adaptive interface.

immune suppression

IL-35 is one molecule that contributes to immune suppression, but it is not the whole story. In tumors, immune suppression often comes from several signals working together, including suppressive cytokines and inhibitory cells. IL-35 fits into that broader pattern by reducing the strength of anti-tumor responses.

Is IL-35 on the IMMUNOBIOLOGY exam?

A quiz or short-answer question might give you a tumor diagram or a scenario and ask which signal is helping the tumor avoid immune destruction. If IL-35 is in the choices, you should connect it to suppression of effector T cells, reduced NK cell activity, and expansion of Tregs. That tells you the tumor microenvironment is becoming more tolerant and less inflammatory.

In a case study, you might be asked to explain why a cancer sample with high IL-35 could show weaker immune control or poorer prognosis. The move is to trace the cause and effect, not just name the cytokine. High IL-35 means more immune braking, which can make immunotherapy harder to succeed unless that suppression is addressed.

IL-35 vs IL-10

Both IL-35 and IL-10 are immunosuppressive cytokines, so they can get mixed up on a quiz. The difference is that IL-35 is especially tied to Tregs and tumor immune evasion, while IL-10 is broader in its anti-inflammatory signaling and comes up in more general immune regulation. If the question centers on suppressing anti-tumor immunity, IL-35 is usually the better fit.

Key things to remember about IL-35

• IL-35 is an immunosuppressive cytokine in Immunobiology, best known for helping turn down anti-tumor immune responses.

• It is mainly produced by regulatory T cells and some B cells, which are both associated with immune restraint.

• IL-35 suppresses effector T cells and natural killer cells, so it weakens two major arms of tumor defense.

• High IL-35 in a tumor usually points to a more suppressive tumor microenvironment and can be linked with poorer outcomes.

• When you see IL-35, think about immune evasion, not just cytokine signaling in general.

Frequently asked questions about IL-35

What is IL-35 in Immunobiology?

IL-35 is an immunosuppressive cytokine in the immune system, produced mainly by regulatory T cells and some B cells. In Immunobiology, it comes up because it helps tumors evade immune attack by reducing effector T cell and NK cell activity.

Is IL-35 the same as IL-10?

No. Both are suppressive cytokines, but they are not interchangeable. IL-35 is more closely tied to Tregs and tumor immune evasion, while IL-10 is often discussed as a broader anti-inflammatory cytokine in immune regulation.

How does IL-35 help a tumor?

IL-35 helps a tumor by dampening the immune cells that would normally attack it. It lowers effector T cell activity, suppresses NK cells, and supports a more tolerant tumor microenvironment, which makes immune clearance harder.

Why does IL-35 matter in cancer cases?

If IL-35 is high in a cancer setting, it can point to stronger immune suppression around the tumor. That can help explain why the immune system is not controlling the cancer well and why therapies that depend on immune activation may face more resistance.